[Drug approval: Olaparib - metastatic castration-resistant prostate cancer with BRCA mutation].

[Drug approval: Olaparib - metastatic castration-resistant prostate cancer with BRCA mutation]. Bull Cancer. 2021 Feb 02;: Authors: Saillant A, Flippot R PMID: 33546874 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/33546874?dopt=Abstract

Source: Bulletin du Cancer - February 2, 2021 Category: Cancer & Oncology Authors: Saillant A, Flippot R Tags: Bull Cancer Source Type: research

More News: Cancer | Cancer & Oncology | Prostate Cancer | Science